Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2003
11/25/2003US6652863 Creating fusion compounds by linking to auto-antigenic sequences
11/25/2003US6652862 Biologically active bactericidal/permeability-increasing protein fragments
11/25/2003US6652861 No cytotoxic ribosome inactivation, no affect on fertility of sperm
11/25/2003US6652860 Peptide, apoEp 1.B, compositions and uses thereof
11/25/2003US6652859 Diagnosis and therapy
11/25/2003US6652858 Administering an OX-2 protein or a nucleic acid encoding it to preventing graft rejection, fetal loss, autoimmune disease, and allergies; immunosuppressants; gene therapy
11/25/2003US6652857 Methods for producing avian verotoxin antitoxin
11/25/2003US6652855 Treatment of LFA-1 associated disorders with increasing doses of LFA-1 antagonist
11/25/2003US6652854 Administering agents that hinder CD30/CD30L (CD30L=ligand of CD30) binding; animal model of arthritis for drug screening
11/25/2003US6652852 Specificity for CD20 antigen
11/25/2003US6652851 Cloning and recombinant production of polistinae venom enzymes, such as phospholipase and hyaluronidase, and immunological therapies based thereon
11/25/2003US6652848 Dendritic cell hybrids
11/25/2003US6652838 Method for treating diabetes mellitus
11/25/2003US6652837 Preparation of novel particles for inhalation
11/25/2003CA2266666C Pharmaceutical formulations of corticotropin releasing factor having improved stability in liquid form
11/25/2003CA2194166C Multi-stage cascase boosting vaccine
11/25/2003CA2106370C Antibiotic compounds
11/25/2003CA2105014C Imidazolidine derivatives
11/25/2003CA2100860C A receptor tyrosine kinase target protein cdna cloning method and hgrb proteins
11/25/2003CA2074166C Method for treating intestinal diseases
11/20/2003WO2003096025A1 Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 4 (gpr4)
11/20/2003WO2003096024A1 Diagnostics and therapeutics for diseases associated with vasoactive intestinal peptide receptor 2 (vpac2)
11/20/2003WO2003096022A2 Screening for peptides inhibiting pp1c binding to bcl-2, bcl-xl and bcl-w proteins
11/20/2003WO2003096020A2 Diagnostics and therapeutics for diseases associated with chemokine receptor 8 (ccr8)
11/20/2003WO2003096017A1 Methods and compositions for inducing an immune response
11/20/2003WO2003095971A2 Posh nucleic acids, polypeptides and related methods
11/20/2003WO2003095678A1 Ldl receptor-related proteins 1 and 2 and treatment of bone or cartilage conditions
11/20/2003WO2003095667A2 Autoimmune conditions and nadph oxidase defects
11/20/2003WO2003095662A2 Simultaneous detection of two analytes produced by a cell under the influence of a putative agent using a pin coated assay system
11/20/2003WO2003095652A2 Expression constructs for producing double-stranded (ds) rna and the use thereof
11/20/2003WO2003095647A2 CHIMERIC snRNA MOLECULES CARRYING ANTISENSE SEQUENCES AGAINST THE SPLICE JUNCTIONS OF THE DYSTROPHIN GENE AND THEIR THERAPEUTIC APPLICATIONS
11/20/2003WO2003095637A1 Combination of a growth factor and a protease enzyme
11/20/2003WO2003095611A2 Androgen-regulated pmepa1 and cancer
11/20/2003WO2003095498A1 Complex of organic medicines and beta-cyclodextrin derivatives and its preparing process
11/20/2003WO2003095490A1 Active complex of alpha-lactalbumin (hamlet) and cofactor
11/20/2003WO2003095489A1 Hexamers of receptors, members of the tnf receptor family, their use in therapy and pharmaceutical compositions comprising the same
11/20/2003WO2003095488A1 Chimeric antagonist anth1
11/20/2003WO2003095487A2 Immunogenic cd1 complexes
11/20/2003WO2003095484A2 Polypeptides increasing p53 expression
11/20/2003WO2003095483A1 Dna encoding for a gtpase activating protein
11/20/2003WO2003095482A2 Novel cyclic peptides and use thereof as anti-microbial agents
11/20/2003WO2003095479A1 Multiple branch peptide constructions comprising from 2 to 16 branches of the peptide rqgys or from 8 to 16 branches of the peptide rqgy providing from the hiv gp41 glycoprotein
11/20/2003WO2003095477A2 Miniprotein ligands and other polypeptides and methods for making and using same
11/20/2003WO2003095476A2 PEPTIDES FOR REGULATION OF UROKINASE (uPA) AND TISSUE TYPE (tPA) PLASMINOGEN ACTIVATOR AND METHOD OF OPTIMIZING THERAPEUTIC EFFICACY
11/20/2003WO2003095474A2 Peptides and methods for the control of obesity
11/20/2003WO2003094985A1 Artificial extracellular matrix and process for producing the same
11/20/2003WO2003094984A1 Bone outgrowth agent and therapeutic agent for osteoporosis
11/20/2003WO2003094983A1 Resorbable pharmaceutical formulation for the continuous release of thrombin
11/20/2003WO2003094973A1 Agent and method for transporting biologically active molecules in cells
11/20/2003WO2003094966A1 Arterialization agent and antiarterialization agent
11/20/2003WO2003094965A2 Modulation of neural stem cells with s1p or lpa receptor agonists
11/20/2003WO2003094958A1 Immunoprotective methods for beta cell neogenesis
11/20/2003WO2003094957A2 Methods of therapy for inducing tolerance
11/20/2003WO2003094956A1 Soluble formulations comprising monomeric insulin and acylated insulin
11/20/2003WO2003094955A1 Intracranial treatment of neuropsychiatric disorders by clostridial neurotoxins such as botulinum toxin
11/20/2003WO2003094953A1 Oxygen carrier, selected from haemoglobin, myoglobin and their derivatives, for treating organ dysfunction/tissue damage caused by an acute supply deficiency
11/20/2003WO2003094952A1 Intratumorally administered lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases
11/20/2003WO2003094951A1 Soluble formulations comprising insulin aspart and insulin detemir
11/20/2003WO2003094950A2 A method of inhibiting the emigration of cells from the intravascular compartment into tissues
11/20/2003WO2003094935A1 The use of the human urinary kininogenase in the manufacture of a medicine for treating and preventing cerebral embolism
11/20/2003WO2003094903A1 A method of treatment
11/20/2003WO2003094899A1 Novel method of preparing programmed-release compositions containing (s)-1-[n-[1-(ethoxycarbonyl)-3-phenylpropyl]-l-alanyl]-l-proline and the product thus obtained
11/20/2003WO2003094885A1 Sublingual pharmaceutical formulation of desmopressin
11/20/2003WO2003094862A2 tRNA SYNTHASE: MODULATORS OF ANGIOGENESIS
11/20/2003WO2003094858A2 Ctp-extended erythropoietin
11/20/2003WO2003094849A2 Ferritin fusion proteins for use in vaccines and other applications
11/20/2003WO2003094844A2 Prostate cancer-related compositions, methods, and kits based on dna macroarray proteomics platforms
11/20/2003WO2003094840A2 Induction of antigen specific immunologic tolerance
11/20/2003WO2003094836A2 Methods and products for enhancing immune responses using imidazoquinoline compounds
11/20/2003WO2003094835A2 Fgf variants and methods for use thereof
11/20/2003WO2003094829A2 Pathogen vaccines and methods for using the same
11/20/2003WO2003094808A1 Methods for therapeutic treatment of carpal tunnel syndrome
11/20/2003WO2003094617A2 Use of vegf for treating bone defects
11/20/2003WO2003072016A3 Pharmaceutical compositions in particulate form
11/20/2003WO2003070196A3 Prevention of viral and bacterial disease in shrimp
11/20/2003WO2003070192A9 Compositions and methods for surrogate antibody modulation of an immune response and transport
11/20/2003WO2003061565A3 Use of calmodulin to promote bone regeneration
11/20/2003WO2003057828A3 Method of producing glycoproteins having reduced complex carbohydrates in mammalian cells
11/20/2003WO2003055995A3 Lipase genes and proteins
11/20/2003WO2003055915A3 Human netrin receptor and uses thereof
11/20/2003WO2003055531A3 A hemostatic kit, a method of preparing a hemostatic agent and a method of promoting hemostasis
11/20/2003WO2003054165A3 Genetic markers and methods for the diagnosis, treatment and prevention of tumor metastasis
11/20/2003WO2003054012A3 Leptin proteins
11/20/2003WO2003050504A3 Methods and compositions to treat cardiovascular disease usin g 1419, 58765 and 2201
11/20/2003WO2003044172A3 Composition comprising and method of using angiopoietin-like protein 3 angptl3
11/20/2003WO2003042360A3 Antisense modulation of inhibitor-kappa b-r expression
11/20/2003WO2003042357A3 Enzymes
11/20/2003WO2003040399A3 Therapeutic methods for nucleic acid delivery vehicles
11/20/2003WO2003040327A3 Novel human proteins, polynucleotides encoding them and methods of using the same
11/20/2003WO2003040183A3 Compounds for the diagnosis/prevention/treatment of alzheimer's disease
11/20/2003WO2003039458A3 TREATMENT OF HUMAN CANCER WITH ADENOVIRAL VECTOR EXPRESSING TNF-α
11/20/2003WO2003038110A3 7118, a human arginine n-methyltransferase family member and uses therefor
11/20/2003WO2003038055A3 Proteins involved in regulation of adipocytes and uses related thereto
11/20/2003WO2003037931A3 Human angiomotin-like protein 1
11/20/2003WO2003037272A3 Thymosin alpha 1 peptide/polymer conjugates
11/20/2003WO2003037249A3 Method for inhibiting the formation of seromas using factor xiii
11/20/2003WO2003036264A3 Treating diseases mediated by metalloprotease-shed proteins
11/20/2003WO2003033529A3 Tr4, tr4 activators, tr4 inhibitors or tr4-associated molecules for treating leukaemic diseases
11/20/2003WO2003033009A3 Novel drug targets for arthritis
11/20/2003WO2003032866A3 Detection and treatment of intravascular lesions
1 ... 1727 1728 1729 1730 1731 1732 1733 1734 1735 1736 1737 1738 1739 1740 1741 1742 1743 1744 1745 1746 1747 ... 3163